Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John-Michael Gamble
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-Lowering Therapies for Three Acute Outcomes
Scientific Reports
Multidisciplinary
Medication Transitions and Polypharmacy in Older Adults Following Acute Care
Therapeutics and Clinical Risk Management
Related publications
Pdb15 - Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors: Systematic Literature Review and Indirect Comparisons
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Navigating the Chemical Space of Dipeptidyl Peptidase-4 Inhibitors
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
Three Ileus Cases Associated With the Use of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Dipeptidyl Peptidase-4 Inhibitors, Pancreatic Cancer and Acute Pancreatitis: A Meta-Analysis With Trial Sequential Analysis
Scientific Reports
Multidisciplinary
Dipeptidyl Peptidase-4 (DPP-4; CD26)
Science-Business eXchange
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes
European Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Effectiveness in Clinical Practice Versus Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Clinical Trials for Type 2 Diabetes: Protocol for Systematic Review
BMJ Open
Medicine
